 | United States - 1977 - 1276 lapas
...protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a practitioner... | |
 | 1984 - 252 lapas
...of the applicant, as well as the merits of the protocol (and shall notify the Administrator of his determination) within 21 days after receipt of the...case of a clinical investigation within 30 days), and he shall be requested to correct the existing defects before consideration shall be given to his submission.... | |
 | 1994 - 374 lapas
...of the applicant, as well as the merits of the protocol (and shall notify the Administrator of his determination) within 21 days after receipt of the...case of a clinical investigation within 30 days), and he shall be requested to correct the existing defects before consideration shall be given to his submission.... | |
 | 1978 - 436 lapas
...of the applicant, as well as the merits of the protocol (and shall notify the Administrator of his determination) within 21 days after receipt of the...case of a clinical investigation within 30 days), and he shall be requested to correct the existing defects before consideration shall be given to his submission.... | |
 | 1995 - 354 lapas
...investigation, the Secretary shall have 30 days to make sis -h determination and notify the vdministrator. The Secretary, in determining the merits of the protocol,...case of a clinical investigation within 30 days), and he shall be requested to correct the existing defects before consideration shall be given to his submission.... | |
 | 1972 - 344 lapas
...protocol. The Secretary, in determining the merits of a research protocol, shall consuit with the Director as to effective procedures to safeguard adequately...substances from legitimate medical or scientific use. If the Secretary finds the applicant qualified and competent and the research protocol meritorious... | |
 | United States. Congress. Senate. Committee on Labor and Public Welfare - 1971 - 2032 lapas
...protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a Sractitioner... | |
 | United States. Congress. Senate. Committee on the Judiciary - 1972 - 1062 lapas
...protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a practitioner... | |
 | United States. Congress. Senate. Committee on the Judiciary - 1972 - 1804 lapas
...protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a practitioner... | |
 | 1973 - 278 lapas
...Director. The Secretary, in determining the merits of the protocol, shall consuit with the Director as to effective procedures to safeguard adequately...within 21 days after receipt of such protocol from the Director (or in the case of a clinical investigation within 30 days) , and he shall be requested to... | |
| |
... practitioner requesting registration, as well as the merits of the research protocol. The Secretary, in determining the merits of each research protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against... 
